Dordaviprone,braintumor

Mashup Score: 1

FDA Approves Dordaviprone as First and Only Treatment for Aggressive Form of Glioma - 5 day(s) ago

Dordaviprone (Modeyso) is now approved to treat recurrent H3 K27M-mutant diffuse midline glioma, an ultra-rare, aggressive brain tumor primarily affecting children.

Source: www.ajmc.com

Categories: General Medicine News

Tweet Tweets with this article
- AJMC_Journal
  
  #Dordaviprone (Modeyso) is now approved to treat recurrent H3 K27M-mutant diffuse midline glioma, an ultra-rare, aggressive #braintumor primarily affecting children. Learn more: https://t.co/TieV8r1ib4 https://t.co/NL9AjS8YG6